Results 151 to 160 of about 15,514,333 (343)
The practice of clinical neurophysiology
Clinical Neurophysiology Practice, 2016 David Burke +2 more
openaire +4 more sources
Psychiatria Danubina, 2013 Much more is known about attitudes toward mental illness and social stigma, the viscious cycle of its consequences and how to fight the social stigma in public, but much less is known about how to combat the stigma and self stigma in clinical practice. Stigma theories have not been enough to understand the feelings and experience of people with mental ...
openaire +2 more sources
Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma
Molecular Oncology, EarlyView.The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias +12 more
wiley +1 more source
The Introduction of New Remedies into Clinical Practice [PDF]
, 1938 J. W. Trevan
openalex +1 more source
Molecular Oncology, EarlyView.TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach +8 more
wiley +1 more source
Art. XXVII.—Clinical Lectures on the Principles and Practice of Medicine. [PDF]
John Hughes Bennett
openalex +1 more source
Diagnosis in daily practice. By Benjamin V. White, M.D., Assistant Clinical Professor of Medicine, Yale University School of Medicine, and Charles F. Geschickter, M.D., Professor of Pathology, Georgetown University Medical School. 9¾ × 7 in. Pp. 693 + xvi with 360 illustrations. 1948. Philadelphia and London: J. B. Lippincott Co. £4 10s. net [PDF]
, 1948 openalex +1 more source
EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines
Molecular Oncology, EarlyView.The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche +8 more
wiley +1 more source